Benjamin Cohen, MD
Gastroenterology · Cleveland, OHNPI 1639339039
Payments from drug & device makers
Across 277 payments — averaging $6756.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.4M
- E.r. Squibb & Sons, L.L.C.$256K
- Janssen Research & Development, LLC$81K
- Genentech, Inc.$73K
- Takeda Pharmaceuticals U.S.A., Inc.$49K
- Boehringer Ingelheim$30K
- plus $31K from 13 others
Across 11 payments — averaging $1120.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$12K
- AbbVie$113
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 133 | $1,351,375 |
| E.r. Squibb & Sons, L.L.C. | 10 | $256,257 |
| Janssen Research & Development, LLC | 19 | $81,459 |
| Genentech, Inc. | 8 | $72,857 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $48,609 |
| Boehringer Ingelheim | 1 | $29,600 |
| Pfizer | 28 | $10,547 |
| Johnson & Johnson | 33 | $7,377 |
| F. Hoffmann-la Roche AG | 1 | $4,008 |
| Bristol Myers Squibb | 6 | $3,564 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $2,657 |
| Lilly USA, LLC | 2 | $2,451 |
| Janssen Global Services, LLC | 1 | $425 |
| Janssen Scientific Affairs, LLC | 1 | $141 |
| Ferring Pharmaceuticals Inc. | 6 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| Amgen | 2 | $40 |
| Sanofi | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $24 |
How this compares
$1,871,576 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Cleveland
- Florian RiederCleveland$8.7M
- Pierre GholamCleveland$1.9M
- Bret LashnerCleveland$628K
- Jeffry KatzCleveland$602K
- Samita GargCleveland$470K
- Stanley CohenCleveland$382K
- Katherine FalloonCleveland$339K
- Mazen IssaCleveland$329K
- Taha QaziCleveland$307K
- Bo ShenCleveland$264K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.